Tilray Brands (TLRY) Shares Outstanding (Diluted Average) (2019 - 2026)
Tilray Brands (TLRY) reported Shares Outstanding (Diluted Average) of $112.7 million for Q1 2026, up 30.9% on a YoY basis from $86.1 million in Q1 2025, and up 2.11% quarter-over-quarter from $110.3 million in Q4 2025.
Tilray Brands (TLRY) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends
Tilray Brands has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $112.7 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 30.9% year-over-year to $112.7 million; the trailing twelve-month figure through Feb 2026 stood at $112.7 million (up 30.9% YoY), and the FY2025 full-year result was $890.3 million, up 19.89% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $112.7 million, up from $110.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $1.1 billion in Q3 2025, with the low at $83.7 million in Q4 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $559.9 million across 5 years, with a median of $615.5 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) jumped 90.69% — and 2025, when it slumped 88.59%.
- Tilray Brands' Shares Outstanding (Diluted Average) stood at $611.7 million in 2022, then rose by 19.46% to $730.8 million in 2023, then sank by 88.54% to $83.7 million in 2024, then surged by 31.77% to $110.3 million in 2025, then grew by 2.11% to $112.7 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $112.7 million (Q1 2026), $110.3 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 112.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 112.68 Mn |
| Nov 30, 2025 | 110.34 Mn |
| Aug 31, 2025 | 1.06 Bn |
| May 31, 2025 | 890.33 Mn |
| Feb 28, 2025 | 86.08 Mn |
| Nov 30, 2024 | 83.74 Mn |
| Aug 31, 2024 | 875.44 Mn |
| May 31, 2024 | 742.65 Mn |
| Feb 29, 2024 | 754.44 Mn |
| Nov 30, 2023 | 730.77 Mn |
| Aug 31, 2023 | 691.19 Mn |
| May 31, 2023 | 617.98 Mn |
| Feb 28, 2023 | 615.53 Mn |
| Nov 30, 2022 | 611.71 Mn |
| Aug 31, 2022 | 575.30 Mn |
| May 31, 2022 | 481.22 Mn |
| Feb 28, 2022 | 478.05 Mn |
| Nov 30, 2021 | 460.25 Mn |
| Aug 31, 2021 | 449.40 Mn |
| May 31, 2021 | 269.55 Mn |